
Dov Gertz
@dovgertz
CEO & Co-Founder of @Converge_Bio. Training LLMs on DNA, RNA, and Protein sequences and using them to design better medications.
ID: 887605571540709378
19-07-2017 09:30:33
24 Tweet
46 Takipçi
343 Takip Edilen




During my sabbatical, one project I really enjoyed was training DNA foundation models with the team at Arc Institute. I've long believed that deep learning should unlock unprecedented improvements in medicine and healthcare — not just for humans but for animals too. I think this




Instead of looking at the S&P500 go down, you can look at the number of biological models and datasets on Hugging Face go up.


At Converge Bio we are building AI-powered solutions across the entire drug life cycle, from R&D to production, such as binder design, transcript optimization target discovery, and drug MoC with RNA single-cell sequencing



🎙️ Excited to share my recent conversation with Ben from Ben | The SaaS CFO on his podcast! We dive into the future of biotech and our work at Converge Bio . Tune in here: 🍏 Apple Podcasts:podcasts.apple.com/us/podcast/con… 🎧 Spotify: open.spotify.com/episode/75wtyS…


I'll be heading out today to showcase Converge Bio at #biotools. Looking forward to connecting with judges, investors, and fellow entrepreneurs. See you there! #BTIRoadTour2025 #StartupPitch #StartupInnovation #Innovation #LifeSciences

